FREDERICK, Md., April 1, 2013 /PRNewswire/ -- BioElectronics
Corporation (OTC Pink: BIEL), maker of consumer medical
electronics, announced today that the Company has received notice
from the United States Patent and Trademark Office that patent
number 8,412,328 is being issued.
This new US patent, our 5 other US patents, and 2 pending
provide us sound intellectual property protection. This
patent includes specific disease state coverage for therapeutic
treatments to reduce pain and inflammation. The engineering
and therapeutic claims collectively cover long lasting pain relief
that is 5x better than OTC drugs, 100% safer, and cost less than
$0.25 for overnight pain relief.
These patents, other intellectual property, and sound clinical
research provides a viable inexpensive pain therapy for the
hundreds of millions of chronic pain suffers worldwide without the
detrimental side effects or risk of addiction of other pain
therapies.
"We appreciate the importance of protecting our intellectual
property both with patents, continual innovation, and our
disruptive marketing strategy," said John
Martinez, Director of Engineering at BioElectronics.
"This patent and our portfolio of international patents provide
confirmation of our sound science and the value of our accumulated
body of knowledge."
About BioElectronics Corporation
BioElectronics is an award winning developer and manufacturer of
clinically proven advanced medical devices. Its products are
ActiPatch® Therapy, for over-the-counter treatment of back pain and
other musculoskeletal ailments, the Allay™ Menstrual Cycle Pain
Therapy, and RecoveryRx™ for surgical procedures and chronic wound
care. For additional information, please see our web site
www.bielcorp.com.
Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com
SOURCE BioElectronics Corporation